Kymera Therapeutics Inc (KYMR)
43.51
-0.54
(-1.23%)
USD |
NASDAQ |
Nov 21, 16:00
43.56
+0.05
(+0.11%)
After-Hours: 20:00
Kymera Therapeutics Price to Book Value: 3.156 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 3.156 |
| November 20, 2024 | 3.195 |
| November 19, 2024 | 3.107 |
| November 18, 2024 | 3.076 |
| November 15, 2024 | 3.043 |
| November 14, 2024 | 3.332 |
| November 13, 2024 | 3.527 |
| November 12, 2024 | 3.627 |
| November 11, 2024 | 3.76 |
| November 08, 2024 | 3.696 |
| November 07, 2024 | 3.616 |
| November 06, 2024 | 3.589 |
| November 05, 2024 | 3.459 |
| November 04, 2024 | 3.414 |
| November 01, 2024 | 3.370 |
| October 31, 2024 | 3.349 |
| October 30, 2024 | 3.458 |
| October 29, 2024 | 3.517 |
| October 28, 2024 | 3.560 |
| October 25, 2024 | 3.481 |
| October 24, 2024 | 3.534 |
| October 23, 2024 | 3.536 |
| October 22, 2024 | 3.507 |
| October 21, 2024 | 3.376 |
| October 18, 2024 | 3.365 |
| Date | Value |
|---|---|
| October 17, 2024 | 3.354 |
| October 16, 2024 | 3.554 |
| October 15, 2024 | 3.248 |
| October 14, 2024 | 3.339 |
| October 11, 2024 | 3.264 |
| October 10, 2024 | 3.135 |
| October 09, 2024 | 3.143 |
| October 08, 2024 | 3.121 |
| October 07, 2024 | 3.061 |
| October 04, 2024 | 3.122 |
| October 03, 2024 | 3.148 |
| October 02, 2024 | 3.263 |
| October 01, 2024 | 3.377 |
| September 30, 2024 | 3.432 |
| September 27, 2024 | 4.591 |
| September 26, 2024 | 4.665 |
| September 25, 2024 | 4.897 |
| September 24, 2024 | 4.941 |
| September 23, 2024 | 4.713 |
| September 20, 2024 | 4.695 |
| September 19, 2024 | 4.623 |
| September 18, 2024 | 4.379 |
| September 17, 2024 | 4.460 |
| September 16, 2024 | 4.571 |
| September 13, 2024 | 4.345 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.539
Minimum
Oct 27 2023
14.24
Maximum
Aug 28 2020
5.146
Average
4.035
Median
Sep 09 2022
Price to Book Value Benchmarks
| Amgen Inc | 20.70 |
| Voyager Therapeutics Inc | 0.898 |
| Denali Therapeutics Inc | 2.644 |
| Vir Biotechnology Inc | 0.7714 |
| Avidity Biosciences Inc | 3.378 |
Price to Book Value Related Metrics
| PS Ratio | 34.59 |
| Price | 43.51 |
| Earnings Yield | -5.38% |
| Market Cap | 2.818B |